Tramadol is used to treat moderate to moderately severe pain. It works by changing how your body senses and responds to pain.[2] Ultram is currently approved and in use across 42 indications[4].[1]
Ultram is one of 863 small molecule programs targeting Acute Pancreatitis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
2828 competitors in Breast Cancer
Ultram
Tecentriq
Trodelvy
Halaven
Tykerb
Adriamycin
Avastin
Nolvadex
Prolia
Gemzar
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Mar 3, 1995
ULTRAM
NDA NDA020281
May 5, 2005
RYBIX ODT
NDA NDA021693
Sep 8, 2005
ULTRAM ER
NDA NDA021692
Dec 30, 2008
RYZOLT
NDA NDA021745
May 7, 2010
CONZIP
NDA NDA022370
Sep 1, 2020
QDOLO
NDA NDA214044
Sources
Details